Patent details

Basic Information

Publication number:

EP2116265

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP090104332

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Reduced-viscosity concentrated protein formulations

French Title of Invention:

Formulations de protéines concentrées à viscosité réduite

German Title of Invention:

Niederviskose konzentrierte Proteinformulierungen

SPC Number:

Dates

Filing date:

04/10/2001

Grant date:

23/12/2020

EP Publication Date:

11/11/2009

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/12/2020

EP B1 Publication Date:

23/12/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

04/10/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/12/2020

 

 

Name:

Genentech, Inc.

Address:

1 DNA Way, South San Francisco, CA 94080-4990, United States (US)

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

Shire, Steven J.

Address:

United States (US)

2

Name:

Liu, Jun

Address:

United States (US)

Priority

1

Priority Number:

240107 P

Priority Date:

12/10/2000

Priority Country:

United States (US)

2

Priority Number:

293834 P

Priority Date:

24/05/2001

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/395; A61K 47/02; A61K 47/12; A61K 47/18;

Publication

European Patent Bulletin

Issue number:

202052

Publication date:

23/12/2020

Description:

Grant (B1)

Filing date	Document type	Number of pages